Spero Therapeutics Inc. (SPRO)
NASDAQ · Healthcare
Spero Therapeutics Inc. Net Income 2016–2025
Spero Therapeutics Inc. annual/quarterly net income history and growth rate from 2016 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Spero Therapeutics Inc. net income for the quarter ending March 31, 2026 was -7.2 M, a 48.05% decrease year-over-year.
- Spero Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -30.2 M, a 40.74% decrease year-over-year.
- Spero Therapeutics Inc. annual net income for 2025 was 8.6 M, a 112.50% decrease from 2024.
- Spero Therapeutics Inc. annual net income for 2024 was -68.6 M, a 400.65% decrease from 2023.
- Spero Therapeutics Inc. annual net income for 2023 was 22.8 M, a 125.40% decrease from 2021.
- Spero Therapeutics Inc. annual net income for 2021 was -89.8 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Spero Therapeutics Inc. Net Income — FAQ
Spero Therapeutics Inc. (SPRO) net income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Spero Therapeutics Inc.'s net income?
Spero Therapeutics Inc. (SPRO) reported net income of $9M for fiscal 2025.
Where can I see SPRO's net income history?
The chart and table above show Spero Therapeutics Inc.'s net income by year and by quarter, including the growth rate.